Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A local anaesthetic and antipruritic component of ointments and bath additives, also used as a sclerosant.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word polidocanol.

Examples

  • Last summer, the Food and Drug Administration approved an injectable drug for sclerotherapy that has been widely used in Europe for years, polidocanol — sold under the brand name Asclera — for use in the tiniest varicose veins, known as spider veins, and for so-called reticular veins that are one to three millimeters in diameter.

    Circulation Solutions Laura Landro 2010

  • The dose of polidocanol should therefore be minimized.

    RedOrbit News - Technology 2010

  • Food and Drug Administration's (FDA) recent approval of Asclera (TM) (polidocanol) Injection, a sclerotherapy treatment for uncomplicated spider and reticular veins.

    RedOrbit News - Technology 2010

  • The FDA approved Asclera (TM) (polidocanol) Injection on March 30, 2010 to sclerose uncomplicated spider veins (varicose veins less than or equal to 1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity, making it the first sclerosant to be approved in over 60 years.

    RedOrbit News - Technology 2010

  • Please see accompanying full prescribing information for Asclera (TM) (polidocanol) Injection.

    RedOrbit News - Technology 2010

  • Severe allergic reactions have been reported following polidocanol use, including anaphylactic reactions, some of them fatal.

    RedOrbit News - Technology 2010

  • The FDA approved Asclera (TM) (polidocanol) Injection on March 30, 2010 to sclerose uncomplicated spider veins (varicose veins less than or equal to 1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity, making it the first sclerosant to be approved in over 60 years.

    RedOrbit News - Technology 2010

  • Food and Drug Administration's (FDA) recent approval of Asclera (TM) (polidocanol) Injection, a sclerotherapy treatment for uncomplicated spider and reticular veins.

    RedOrbit News - Technology 2010

  • Asclera (TM) (polidocanol) Injection is indicated to sclerose uncomplicated spider veins (varicose veins, less than or equal to 1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity.

    RedOrbit News - Technology 2010

  • Asclera (TM) is contraindicated for patients with known allergy (anaphylaxis) to polidocanol and patients with acute thromboembolic diseases.

    RedOrbit News - Technology 2010

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.